Table of Contents
Introduction
Global Medical Marijuana Market size is expected to be worth around USD 30 Billion by 2032 from USD 14.9 Billion in 2023, growing at a CAGR of 8.3% during the forecast period from 2023 to 2032.
The medical marijuana market is experiencing significant substantial growth, driven by a deepening appreciation of its therapeutic benefits, such as pain relief, appetite enhancement, and the reduction of intraocular pressure. Derived from two primary strains—Cannabis Sativa and Cannabis Indica—medical cannabis has roots in the western hemisphere and Central & South Asia, respectively.
The market’s expansion has historically been constrained by regulatory barriers and production challenges that limited extensive clinical testing of cannabis’s medical potential. Nonetheless, cannabinoids have been increasingly utilized to manage symptoms associated with conditions like HIV/AIDS, chemotherapy-induced nausea, and certain rare neurological disorders.
The inclination towards edible cannabis products is expected to further drive market growth. According to a 2023 survey by New Frontier Data, a significant shift in consumer preference was observed, with 69% of young adults aged 18 to 24 in the United States preferring marijuana over alcohol in 2022. This trend extends beyond the younger demographics, indicating a wider cultural acceptance that could boost demand for cannabis.
With ongoing advancements in regulatory frameworks and continued clinical research to validate the safety and efficacy of cannabis, the medical marijuana market is anticipated to expand significantly. This growth is supported by the increasing legalization of cannabis for both medicinal and recreational use across various North American regions.
Key Takeaways
- Market Size: Global Medical Marijuana Market size is expected to be worth around USD 30 Billion by 2032 from USD 14.9 Billion in 2023.
- Market Growth: The market growing at a CAGR of 8.3% during the forecast period from 2023 to 2032.
- Product Type Analysis: The Oil and tincture segment held the largest market share of 53.4% in 2022.
- Application Analysis: The chronic pain segment dominated the market by holding a market share of 26% in 2022.
- End-Use Analysis: The pharmaceutical segment dominated the market.
- Regional Analysis: North America dominated the market in 2022 by holding the largest revenue share of 74% in the 2022
Medical Marijuana Statistics
Regulatory and Market Dynamics:
- Over 90% of cannabis retailers in the US verified customers’ ages in 2022.
- A significant portion, 87.3%, had signs restricting access to minors, and 73.3% displayed signs against onsite consumption.
Consumer Preferences:
- The preference for cannabis over alcohol is notable among young adults, with 69% of those aged 18 to 24 favoring marijuana.
- Edibles are emerging as a preferred form of consumption, though they are generally less potent compared to other forms like oils and e-liquids.
Health and Safety Communications:
- 72% of retailers posted warnings about the use of cannabis during pregnancy or breastfeeding.
- General health risk advisories were displayed by 38% of retailers, while 18.7% warned about impacts on children and youth.
Economic Impact:
- The legal cannabis sector supports nearly 428,059 jobs and is projected to grow significantly, potentially reaching 1.1 million jobs by 2025.
- Cannabis sales reached $21.1 billion in 2022 in the US alone.
Medical and Therapeutic Use:
- Medical marijuana is used primarily for pain management, making up nearly 75% of the market.
- Significant percentages of users consume cannabis for managing stress (21.9%) and other mental health issues (21.5%).
Legal Landscape and Support:
- 91% of US adults support the legalization of cannabis, with a notable majority using it for medical purposes.
- Legalization trends suggest that more states will continue to adopt friendly cannabis laws, potentially giving 96% of Americans access to legal marijuana within the next decade.
Emerging Trend
- Increasing Potency: There’s a notable increase in the THC concentration of cannabis products, which raises concerns about health risks such as addiction and cognitive impairment.
- FDA Approvals: The U.S. FDA has approved cannabinoid-based medications such as Dronabinol and Epidiolex for specific medical uses, highlighting the therapeutic potential of cannabis-derived products.
- Neurological Applications: Research at Stanford has shown that marijuana-like substances in the brain can impact conditions like epilepsy, suggesting potential new avenues for therapeutic applications.
- Risks of High Potency: As cannabis products become more potent, there’s growing concern about their safety, particularly regarding their impact on mental health and cognitive function.
- Expanded Legalization: The legalization of medical cannabis continues to expand, with many states adopting laws that facilitate its medical use, reflecting growing public and governmental acceptance.
- Senior Use Increasing: Usage among older adults is growing, reflecting reduced stigma and increasing recognition of the potential health benefits of cannabis for age-related conditions.
- Research on Safe Use: Ongoing research aims to balance the therapeutic benefits of cannabis with potential risks, striving for formulations and dosages that maximize health benefits while minimizing adverse effects.
- Medical Training and Awareness: There’s a push for better training for healthcare providers regarding the safe prescription and monitoring of medical cannabis use to ensure informed and effective patient care.
- Regulatory Evolution: Regulatory frameworks are evolving to accommodate the increasing acceptance of medical marijuana, which involves adjusting guidelines for usage, prescription, and sales to ensure consumer safety and product efficacy.
- Public Health Implications: Studies continue to examine the broad public health implications of widespread medical and recreational cannabis use, including its impact on public safety, mental health, and substance use disorders.
Use Cases
- Pain Management: Medical marijuana is frequently utilized for managing chronic pain, offering an alternative to traditional pain medications.
- Neurological Disorders: There’s evidence supporting the use of cannabinoids in treating certain neurological conditions such as epilepsy, particularly through the modulation of neurotransmitter activity.
- Mental Health Management: Cannabis is being studied for its potential benefits in treating mental health disorders such as anxiety and depression, although the results are mixed and call for cautious application.
- Cancer-Related Symptoms: THC, a component of cannabis, is effectively used to alleviate nausea and appetite loss in cancer patients undergoing chemotherapy.
- Sleep Disorders: Some patients with insomnia may experience improved sleep with the use of medical marijuana, although this is specific to individual cases.
- Addiction Management: Cannabis is also being explored as a less harmful substitute in harm reduction strategies for individuals addicted to more dangerous substances like opioids.
- Cognitive Health: Research is ongoing into how long-term cannabis use affects cognitive health, with some studies suggesting potential risks particularly with high THC content.
- Public Health Benefits: Legalization of medical marijuana can reduce the illegal market and provide regulated, safe access to cannabis for therapeutic use, contributing to public health and safety.
- Withdrawal Management: Medical marijuana can help manage withdrawal symptoms in patients transitioning off more addictive substances, although it also has its own potential for dependence.
- Treatment of Psychotic Disorders: There’s growing interest in the impact of cannabis on psychotic symptoms, particularly its risks and benefits for patients with or at risk of schizophrenia.
Conclusion
The medical marijuana market is poised for substantial growth, supported by increased consumer acceptance and a broader understanding of its therapeutic benefits. With regulations evolving and more states moving towards legalization, access to medical cannabis is expanding, further stimulating market growth.
The market’s potential is underscored by its diverse applications in pain management, mental health, and chronic illnesses, among others. However, the increase in potency and the potential health risks associated with high THC content warrant careful regulation and further research to ensure safe and effective use. Overall, the outlook for the medical marijuana market remains robust and promising.
Discuss Your Needs With Our Analyst
Please share your requirements with more details so our analyst can check if they can solve your problem(s)
